Whoever said wishes don’t come true hasn’t explored our offers!
  • Lupin Share Price

    Lupin is one of the largest generic pharmaceutical companies in the world. They are headquartered in Mumbai, India.

    Market Capitalisation

    As of March 2018, Lupin has a market capitalisation of about Rs.33,000 crore.

    Wealth and recent performance

    Q1 FY 2018-19
    • For the quarter ended on June 30, 2018, Lupin Limited reported its total revenue from operations to be at Rs.38,560 million. Compared to the same quarter of the previous year, it marks a marginal decrease of 0.4%.
    • Earnings before interest, tax, depreciation, and amortization (EBITDA) for the June quarter were reported to be at Rs7,112 million as against an EBITDA of Rs.8,003 million reported for the corresponding quarter of the last year.
    • The company’s net profit before exceptional items incurred a drop of 43.4% y-o-y. The final figure for the quarter was reported to be at Rs.2,028 million, as against a profit of Rs.3,581 million in the Q1 FY18.
    • The company’s net debt-equity ratio, as of June 30, 2018, was reported to be at 0.40.
    FY 2017-18
    • For the year ended on March 31, 2018, Lupin Limited reported its sales to be at Rs.155,598 million. Comparing this figure with the one reported for the previous fiscal year, the sales for the FY18 have decreased by 9.1%.
    • A similar decrease was also seen in the company’s EBITDA y-o-y. For the FY 2018, the company disclosed its EBITDA to be Rs.32,979 million, as against Rs.45,997 reported for the previous fiscal year. This translates into a drop of 28.3%.
    • Consequently, the net profit before exceptional items has also come down. The figure, as of March 31, 2018, was stated to be Rs.13,934 million - a 45.6% drop y-o-y. This drop was incurred on account of reassessment of deferred tax assets and liabilities related to the company’s US operations.
    • For the year, the material cost and personnel cost increased respectively by 577 basis points and 131 basis points. The company’s net debt-equity ratio was 0.41. As for its basic earnings per share (EPS), it was reported to be Rs.30.83 as against an EPS of Rs.56.69 stated for the previous fiscal year.
    Q3 FY 2017-18
    • According to the unaudited standalone financial results for the third quarter of the financial year ending 2017–2018, the total income of Lupin was Rs.25,552.3 million. This was a drop from the total income in the previous quarter which stood at Rs.26,543.3 million.
    • The total income of the company in the third quarter of the previous financial year was, Rs.33,848.4 million.
    • The total expenses of the company dipped from Rs.21,445.1 million in the second quarter of FY18 to Rs.21,390.1 million in the third quarter of the same financial year.
    • The total expenses of the company in the third quarter of the previous financial year were Rs.21,621.9 million.
    • The profit before tax for the company in the third quarter of the FY18 was, Rs.4,162.2 million. This was a dip from the profit before tax for the previous quarter which was Rs.5,098.2 million.
    • The profit before tax for the company in the third quarter of the previous financial year was, Rs.12,226.5 million.
    • Net profit for the company after tax was, Rs.3,091.8 million in the third quarter of the FY18 which was a dip from the previous quarter which was, Rs.3,889.0 million.
    • The net profit for the company after tax in the third quarter of the previous financial year was, Rs.8,594.7 million.
    Stock trend in 2018
    • In January 2018, Lupin’s stock began trading at about Rs.883. The price of the stock then steadily increased through the first two weeks of the month. After the third week, the stock spiked to about Rs.959 which was also the highest price for the month.  After this, the stock declined for the rest of the month. By the end of the month, the stock closed at about Rs.883.
    • In February 2018, the stock opened at about Rs.860 which was a solid decrease in price from Rs.883. The decline in prices continued throughout the first week of the month with the stock touching about Rs.800. After this, the stock seemed to pick up a little, but the stock never went over Rs.841 for the rest of the month. The stock closed at about Rs.819 at the end of the month.
    • In March, the stock declined some more to open at about Rs.803. The decline in prices continued through the first and second weeks of March. During those two weeks, the lowest price was about Rs.761. The stock seemed to pick up a little but by 23 March, 2018, the stock had dipped to about Rs.734.
    • On March 30, 2018, the closing share price of Lupin Limited was Rs.735.85 on the NSE. In April, the prices recovered by a little over 8% to cross the Rs.780 mark. In the second half of the month, the shares managed to enter the Rs.800 region, although they failed to find a steady heading at those levels.
    • In May, the Lupin shares shed their gains in a gradual manner. The stock price went below the Rs.750 mark and eventually, it reached its 52-week low at Rs.723.55.
    • Over the course of June, the shares staged a remarkable recovery. From trading at levels above Rs.760, the shares soared to touch the Rs.900 mark by mid-June. For the remainder of the month, the Lupin shares were seen trading at levels varying from Rs.890 - Rs.920.
    • In July, however, the shares shed those gains to retreat back to their previous levels at Rs.800. At the end of the month, the company announced a final dividend of 250%. The share price rose gradually once again in August and the scrip ascended back into the Rs.900 region. On August 31, the shares concluded the trading at Rs.931.45.

    Stock trend in 2018

    • In January 2018, Lupin’s stock began trading at about Rs.883. The price of the stock then steadily increased through the first two weeks of the month. After the third week, the stock spiked to about Rs.959 which was also the highest price for the month.  After this, the stock declined for the rest of the month. By the end of the month, the stock closed at about Rs.883.
    • In February 2018, the stock opened at about Rs.860 which was a solid decrease in price from Rs.883. The decline in prices continued throughout the first week of the month with the stock touching about Rs.800. After this, the stock seemed to pick up a little, but the stock never went over Rs.841 for the rest of the month. The stock closed at about Rs.819 at the end of the month.
    • In March, the stock declined some more to open at about Rs.803. The decline in prices continued through the first and second weeks of March. During those two weeks, the lowest price was about Rs.761. The stock seemed to pick up a little but by 23 March, 2018, the stock had dipped to about Rs.734.

    Stock history (2016–2017)

    • Lupin’s stock began trading at about Rs.1,783 in January 2016. This was followed by a decline over the first two weeks, with the stock touching a low of about Rs.1,666. The stock seemed to pick up again but the performance was not enough to reach the high it began with for the month. The stock closed at about Rs.1,710 for the month. The stock opened at about Rs.1,702 for the month of February 2016. The stock declined for a few days before spiking to about Rs.1,905 in the second week. This was followed by a decline and the stock closed at about Rs.1,754 for the month. In March 2016, the stock opened at about Rs.1,761 and increased in price for the first two weeks. This resulted in the stock touching a high of about Rs.1,869. Then, the stock continued on a steep decline and the stock closed at about Rs.1,479 for the month.
    • In April 2016, the stock opened at about Rs.1,464. The stock gained steadily throughout the month to close at about Rs.1,607. In May 2016, the stock opened at about Rs.1,619. This was a good gain from the price it closed at for the previous month. Till about the end of the third week of May 2016, the stock remained at over Rs.1,600 after which it dropped below that mark. By the fourth week of May, the stock had dropped to below Rs.1,500 and closed for the month at about Rs.1,474. In June 2016, the stock opened at about Rs.1,490. The stock dropped for the first week. Then, the stock began gaining and this gain in price continued for the rest of the month. By the end of June 2016, the stock closed at about Rs.1,539.
    • In July 2016, the stock opened at about Rs.1,552 which was a good gain from the price it had closed at for the previous month. July was a period of solid gain which saw the stock price breach the Rs.1,600 mark. Towards the end of the month, the stock had breached the Rs.1,700 mark too. In the last week of July 2016, a final dividend of 375% was announced by the company. In August 2016, the stock opened at about Rs.1700. August 2016 saw a period of decline in which the stock touched a low of Rs.1,482 which was also the price at which the stock closed at for the month. In the beginning of September 2016, the stock again breached the Rs.1,500 mark. The stock gained greatly for the first week, touching Rs.1,582. This was followed by a period of decline in which the stock closed at about Rs.1,486 for the month.
    • In October 2016, the stock opened at about Rs.1,493. By the end of the first week, the stock had breached the Rs.1,500 mark but the stock soon dropped to below that. By the end of October 2016, the stock closed at about Rs.1,518. The stock opened in November 2016, at a price over Rs.1,500 but this did not last long. The price dropped a lot during the month. The lowest price of the stock for that month was about Rs.1,398. By the end of the November, the stock had regained a price that was above Rs.1,500. In December 2016, the stock opened at about Rs.1,512. The stock declined a lot during the month, with a low of about Rs.1,402. The stock closed for the month at about Rs.1,486.
    • The stock opened at about Rs.1,505 in January 2017. The stock fluctuated a lot over the course of the month. The stock closed at about Rs.1,470 for the month. In February 2017, the stock opened at about Rs.1,474. The stock appeared to gain for the first week, with a high price of Rs.1,496. The stock then fluctuated in price for the rest of the month and closed at about Rs.1,474 for the month. In March 2017, the stock opened at about Rs.1,469. The stock remained steady for a short period before declining in price and closing for the month at about Rs.1,445.
    • In April 2017, the stock opened at a price of about Rs.1,434. For the rest of the month, the stock declined in price, reducing so much as to close at about Rs.1,338 for the month. In May 2017, the stock opened at about Rs.1,338. The stock declined for the first week and till about the end of the second week. The lowest price during this time was about Rs.1,252. The stock gained in the third week to touch about Rs.1,318 but declined again to close for the month at about Rs.1,161. In June 2017, the stock opened at about Rs.1,146. The stock gained minimally for the first two weeks to reach about Rs.1,182 but declined again for the rest of the month to close at about Rs.1,059.
    • The stock opened at about Rs.1,054 in July. The stock gained strongly for the first two weeks and till the end of the third week. The stock touched a high of about Rs.1,172. A final dividend of 375% was announced by the company towards the end of the month. The stock dropped after that to close for the month at about Rs.1,032. The stock opened even lower in August 2017, at about Rs.1,017. The stock declined steadily for the first three weeks of August 2017 and even went below the Rs.1,000 mark. The stock gained a little in the last week to close at about Rs.979 for the month. The stock opened at about Rs.995 in September 2017. The stock gained a price over Rs.1,000 only towards the end of the second week. The stock closed for the month at about Rs.1,014.
    • In October 2017, the stock opened at about Rs.1,014. The stock remained at over Rs.1,000 for the first three weeks of the month and dipped below Rs.1,000 again towards the end of the month. The stock gained again to close at about Rs.1,028 for the month. The stock opened at about Rs.1,061 for November 2017. There was a steep drop in prices for the first week of November, with the stock dropping below the Rs.900 mark. In the second week of November, the stock dropped below Rs.850. By the end of November 2017, the stock closed at about Rs.817. In December 2017, the stock opened even lower, at about Rs.814. The stock continued to drop with a low of about Rs.808 in the first week. In the second week, the stock began gaining in price to close for the month at about Rs.885.

    Should one invest in Lupin?

    • Lupin has achieved a number of records in recent years.
    • According to Bloomberg, in 2017, Lupin was the seventh largest generic pharmaceutical company by market capitalisation and the sixth largest company in the generic pharmaceutical category with regard to total revenue.
    • In India, the company was the second largest pharmaceutical company by total revenue in 2017.
    • In addition to all this, Lupin was the sixth largest generic pharmaceutical company in Japan in 2017.
    • Also, it is to be noted that Lupin had a consolidated sales amount of Rs.1,71,198 million in FY17 and a net profit of Rs.25,575 million in the same time period.
    • The company has products that address cardiovascular health, diabetes, asthma, gastro-intestinal issues, et cetera. These are all health issues that require regular medication.
    • The company has reported solid sales growth in 20151 2016, and 2017.
    • While a number of reasons can given for investing in Lupin stocks, it would be better to invest after performing personal research, keeping in mind financial freedom and risk appetites.

    Company information

    Lupin is based on the idea that their products need to make a difference in the lives of the people who use them. The company is a leader in the pharmaceutical industry in countries like, India, Japan, and the US. The company relies on cutting-edge research that is supplemented by world-class manufacturing facilities. The company was the second largest pharmaceutical company in India with regard to total revenue in the FY17. The company achieved a consolidated sales of Rs.1,71,198 million in the FY17 with a net profit of Rs.25,575 million.

    Company History

    The company was founded by a person called, Desh Bandhu Gupta. He was an Associate Professor at BITS-Pilani in Rajasthan. The company was founded in the year, 1968. Mr. Desh Bandhu Gupta remained as Chairman until he passed away in 2017. His wife replaced him as Chairman. The company was named after the Lupin flower. The company’s vision was to combat life-threatening diseases using drugs. When the company developed a tuberculosis drug, subsequently becoming the world’s largest manufacturers of the same. This brought them global recognition.

    Management

    Mrs. Manju D Gupta is the Chairman of Lupin. Dr. Kamal K Sharma is the Vice Chairman. The Chief Executive Officer is Ms. Vinita Gupta. Mr. Nilesh Gupta is the Managing Director. Mr. Ramesh Swaminathan is the Chief Financial Officer and an Executive Director. Other than these key members, there are six Independent Directors.

    Listing information

    Lupin’s shares are traded on the BSE and the NSE.

    BSE: 500257; NSE: LUPINEQ; ISIN code: INE326A01037; Sector: Pharmaceuticals and health care; Industry: Pharmaceuticals

    Lupin also forms a part of indices like, Nifty 50, MCX-SX 40 Index, S&P BSE 100, et cetera.

    Lupin is also listed on the Bangalore Stock Exchange Limited, Cochin Stock Exchange Limited, and so on.

    Location

    Corporate office

    Lupin Ltd, B/4 Laxmi Towers, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051, India

    Ph: +91 22 6640 2222

    Fax: +91 22 6640 2130

    Registered office

    Lupin Ltd, 3rd floor Kalpataru Inspire, Off W E Highway, Santacruz (East), Mumbai – 400 055, India

    Ph: +91 22 6640 2323

    Fax: +91 22 6640 2051

    Stocks vs. Mutual Funds: here's what we recommend

    Stock market investments require a lot of research and knowledge. They do not generally offer any tax benefits and are regarded as high-risk investments. Hence,it is crucial to have a diversified portfolio. At Bankbazaar, we encourage our readers to invest on mutual funds . It doesn't require a lot of knowledge and equity linked mutual fund schemes offer tax benefits. Additionally, since mutual funds comprise stocks from multiple companies, they help in building a diversified portfolio.

    DISCLAIMER:

    The contents of this post/blog does not constitute financial or other professional advice nor does it imply in any manner a principal-agent relationship, and is not a professional advice on a specific financial matter.

    reTH65gcmBgCJ7k
    This Page is BLOCKED as it is using Iframes.